WELLINGTON MANAGEMENT GROUP LLP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$12,737,000
-13.0%
568,382
-3.8%
0.00%0.0%
Q2 2022$14,637,000
-48.4%
590,679
-19.2%
0.00%
-40.0%
Q1 2022$28,346,000
-30.8%
731,125
+4.5%
0.01%
-28.6%
Q4 2021$40,943,000
+13.1%
699,752
+14.6%
0.01%
+16.7%
Q3 2021$36,186,000
+66.1%
610,540
+143.2%
0.01%
+50.0%
Q2 2021$21,785,000
+46.4%
251,005
+39.1%
0.00%
+33.3%
Q1 2021$14,878,000
-15.8%
180,448
-7.1%
0.00%0.0%
Q4 2020$17,663,000
+2211.9%
194,245
+398.0%
0.00%
Q4 2019$764,000
-82.6%
39,006
-97.0%
0.00%
-100.0%
Q4 2015$4,403,000
-43.5%
1,306,569
-10.7%
0.00%
-50.0%
Q3 2015$7,796,000
-19.7%
1,462,522
-2.5%
0.00%
-33.3%
Q2 2015$9,703,000
+36.1%
1,499,648
+2.9%
0.00%
+50.0%
Q1 2015$7,128,000
-0.3%
1,457,698
+2.6%
0.00%0.0%
Q4 2014$7,147,000
-2.0%
1,420,928
+0.1%
0.00%0.0%
Q3 2014$7,293,000
-3.2%
1,418,975
+18.8%
0.00%0.0%
Q2 2014$7,533,000
-31.0%
1,194,010
+6.5%
0.00%
-33.3%
Q1 2014$10,920,000
+45.3%
1,121,180
-6.3%
0.00%
+50.0%
Q4 2013$7,518,0001,197,2000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders